Characterizing Colon Cancer Chemotoxicity Risk based on Epigenetic Age and Modification by Resistance Training Intervention
This study will investigate whether epigenetic aging — a molecular marker of biological age — at the start of chemotherapy is associated with chemotoxicity in patients receiving treatment for colon cancer. We will also look at whether chemotherapy treatment is associated with changes in epigenetic age, and the impact that resistance training during chemotherapy treatment has on these associations.
Investigator: Caan, Bette
Funder: National Cancer Institute
